ArticleStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2021

Comparison of EBRT and I-125 seed brachytherapy concerning outcome in intermediate-risk prostate cancer.

Matthias Moll et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.